France’s Medical Marijuana Trial Faces Uncertainty As New Amendment Tries To Keep It Running
The medical marijuana trial has once again been “forgotten” from the 2025 Social Security Financing Bill (PLFSS), but the new amendment aims to get it back, writes Newsweed.
Ensemble pour la République deputies Michel Lauzzana (Lot-et-Garonne) and Jean-François Rousset (Aveyron), with help from Santé France Cannabis proposed an amendment aiming to correct this “oversight,” which could leave close to 2,000 people without medical marijuana treatment. The legislation proposes to extend the medical marijuana experiment until medication is authorized and no later than Dec. 31 2025.
Previously, the experiment was set to end in March 2024, but last Oct. it was confirmed that the trial would continue. The country’s then Minister for Health Aurélien Rousseau said at the time the experiment resulted in “clinical feedback showing a benefit for the patient.” Rousseau added that the reason he would not allow for a full medical marijuana rollout across France is because there’s no “European marketing authorization.”
In 2023, France …